Abclonal Uk Limited in Port Talbot, SA12 7AX

Description

Data updated on: 01-11-2023

Abclonal Uk Limited is established as Private Limited Company, that is based in Unit 4, Baglan Bay Innovation Centre, Port Talbot. The zip code is SA12 7AX. This firm was set up in 2021. The firm's registration number is 13740530. The enterprise's SIC and NACE codes are 72110 which stands for Research and experimental development on biotechnology.

Currently, this limited company is presided over by a solitary director: Jieyu Z., who was arranged to perform management duties in January 2024. Since 2021 Xiao P., had been performing the duties for the following limited company up until the resignation on 2024-01-30.

The companies that control this firm include: Wuhan Abclonal Biotechnology Co., Ltd owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Dong Hu New Technology Development Zone at Wuhan Guang Gu International Biomedical Companies, 388 Gao Xin Second Road, Wuhan.

Financial data based on annual report

Profit & Loss
Date of Accounts	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand	144 872
Current Assets	383 345
Debtors	151 124
Other Debtors	1 050
Property Plant Equipment	52 118
Total Inventories	87 349

Other Financial Data
Audit Fees Expenses	9 485
Accrued Liabilities Deferred Income	11 350
Accumulated Depreciation Impairment Property Plant Equipment	13 359
Additions Other Than Through Business Combinations Property Plant Equipment	65 477
Administrative Expenses	282 977
Amounts Owed To Group Undertakings	311 365
Applicable Tax Rate	19
Average Number Employees During Period	5
Cash Cash Equivalents Cash Flow Value	144 872
Comprehensive Income Expense	-160 534
Cost Sales	192 975
Creditors	394 613
Depreciation Expense Property Plant Equipment	13 359
Depreciation Rate Used For Property Plant Equipment	20
Finance Lease Liabilities Present Value Total	4 020
Gain Loss In Cash Flows From Change In Accrued Items	10 985
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables	68 243
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables	-151 124
Gain Loss In Cash Flows From Change In Inventories	-87 349
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss	-6 918
Gross Profit Loss	122 930
Income Expense Recognised Directly In Equity	200 000
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation	144 872
Increase Decrease In Net Debt From Cash Flows	171 897
Increase From Depreciation Charge For Year Property Plant Equipment	13 359
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings	487
Interest Paid Classified As Operating Activities	487
Interest Payable Similar Charges Finance Costs	487
Issue Equity Instruments	200 000
Net Cash Flows From Used In Financing Activities	516 769
Net Cash Flows From Used In Investing Activities	-65 477
Net Cash Flows From Used In Operating Activities	-306 420
Net Cash Generated From Operations	-305 933
Net Debt Funds	171 897
Number Shares Issued Fully Paid	50 000
Operating Profit Loss	-160 047
Other Creditors	10 623
Other Taxation Social Security Payable	57 255
Par Value Share	1
Payments Finance Lease Liabilities Classified As Financing Activities	-5 404
Prepayments Accrued Income	1 050
Proceeds From Issuing Shares	200 000
Proceeds From Repayment Loans Advances To Group Undertakings Classified As Financing Activities	311 365
Production Average Number Employees	4
Profit Loss	-160 534
Profit Loss On Ordinary Activities Before Tax	-160 534
Property Plant Equipment Gross Cost	65 477
Purchase Property Plant Equipment	65 477
Raw Materials	87 349
Revenue From Sale Goods	315 905
Tax Expense Credit Applicable Tax Rate	30 501
Tax Increase Decrease From Effect Capital Allowances Depreciation	1 780
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss	-1 295
Tax Increase Decrease From Other Short-term Timing Differences	-40 773
Total Assets	435 463
Total Liabilities	435 463
Trade Debtors Trade Receivables	149 024
Turnover Revenue	315 905
Wages Salaries	120 476
Director Remuneration	40 200

Company staff

Jieyu Z.

Role: Director

Appointed: 01 January 2024

Latest update: 2 April 2024

People with significant control

Wuhan Abclonal Biotechnology Co., Ltd

Address: Room 01, 4th Floor, Block 7, 1 Phase Wuhan Guang Gu International Biomedical Companies, 388 Gao Xin Second Road, Dong Hu New Technology Development Zone, Wuhan, China

Legal authority Companies Act 2006

Legal form Private Limited Company

Notified on 7 April 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Peggrem S.

Notified on 3 March 2022

Ceased on 7 April 2022

Nature of control:

over 3/4 of shares

Xiao P.

Notified on 12 November 2021

Ceased on 3 March 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	12 November 2023
Confirmation statement next due date	02 June 2024
Confirmation statement last made up date	19 May 2023

Annual Accounts
Start Date For Period Covered By Report	2021-11-12
End Date For Period Covered By Report	31 December 2022

Abclonal Uk Limited

General information

Name:

Office Address:

Description

Financial data based on annual report

Company staff

Jieyu Z.

Xiao P.

People with significant control

Wuhan Abclonal Biotechnology Co., Ltd

Peggrem S.

Xiao P.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode